5 Results for "

INSM1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "INSM1" in MCE Product Catalog:

Cat. No.: HY-RS06844
Research Areas:  

Others

INSM1 Human Pre-designed siRNA Set A contains three designed siRNAs for INSM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS20042
Research Areas:  

Others

Insm1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Insm1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26545
Research Areas:  

Others

Insm1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Insm1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-183067
CAS No.: 2098585-77-2
Research Areas:  

Cancer

TAS1440 is an orally active LSD1/KDM1A inhibitor with a human IC50 of 4.8 nM. TAS1440 non-covalently binds to the histone H3-binding pocket of LSD1, inhibiting demethylase activity and disrupting repressive complexes with INSM1 and SMAD2. TAS1440 activates tumor-suppressive TGF-β and NOTCH signaling pathways via transcriptional reprogramming. TAS1440 can be used for the research of small cell lung cancer, specifically the SCLC-A subtype [1].
loading...
    loading...
Cat. No.: HY-183067A
CAS No.: 2642224-15-3
Research Areas:  

Cancer

TAS1440 benzoate is an orally active LSD1/KDM1A inhibitor with a human IC50 of 4.8 nM. TAS1440 benzoate non-covalently binds to the histone H3-binding pocket of LSD1, inhibiting demethylase activity and disrupting repressive complexes with INSM1 and SMAD2. TAS1440 benzoate activates tumor-suppressive TGF-β and NOTCH signaling pathways via transcriptional reprogramming. TAS1440 benzoate can be used for the research of small cell lung cancer, specifically the SCLC-A subtype [1].
loading...
    loading...